Related Articles
Lidocaine attenuates TMZ resistance and inhibits cell migration by modulating the MET pathway in glioblastoma cells
Temozolomide inhibits cellular growth and motility via targeting ERK signaling in glioma C6 cells
TRIM31 enhances chemoresistance in glioblastoma through activation of the PI3K/Akt signaling pathway
Estrogen receptor β agonist enhances temozolomide sensitivity of glioma cells by inhibiting PI3K/AKT/mTOR pathway
BKM120 sensitizes C6 glioma cells to temozolomide via suppression of the PI3K/Akt/NF‑κB/MGMT signaling pathway